Clinical Study of Ayurvedic Formulations in Managment of Anurjatajanya Shwas (Atopic asthma)

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2023
INTERVENTION: CONDITION: Health Condition 1: J454‐ Moderate persistent asthma Health Condition 2: J682‐ Upper respiratory inflammation dueto chemicals, gases, fumes and vapors, not elsewhere classified PRIMARY OUTCOME: 1. Etiopathogenesis of Anurjatajanya Shwasa w. s. r. to atopic asthma. ; 2. Therapeutic efficacy of Amritadi Kwath in Anurjatajanya Shwasa w. s. r. to atopic ; asthma. ; 3. Therapeutic efficacy of Shunthyadi Churna in Anurjatajanya Shwasa w. s. r. to atopic ; asthmaTimepoint: 2 month SECONDARY OUTCOME: 1. Changes in clinical assessment criteria. ; 2. Changes in Ig E. ; 3. Changes in spirometry. ; 4. Changes in eosinophil count. ; Timepoint: 45 days INCLUSION CRITERIA: Diagnosed cases of Anurjatajanya shwasa w. s. r. to atopic asthma. Patients will be selected irrespective of sex, caste, occupation, socio‐ economic status.
Epistemonikos ID: 8dbbe286e0712a2bef97499833d7be225f1fc858
First added on: Feb 20, 2024